Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Human Gene Therapy
|
December 16, 1998
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination
R Furlan, P L Poliani, F Galbiati, et al.
Gene Therapy
|
August 3, 2012
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia
C Maiorino, R Khorooshi, F Ruffini, et al.
Clinical Chemistry
|
March 3, 1999
TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis
D Franciotta, G Martino, E Brambilla, et al.
Journal of Clinical Pharmacology
|
April 29, 1998
Pharmacokinetics of isosorbide dinitrate in healthy volunteers after 24-hour intravenous infusion
A Bergami, R Bernasconi, S Caccia, et al.
Gene Therapy
|
August 25, 2006
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice
R Furlan, A Bergami, E Brambilla, et al.
Journal of Neuroimmunology
|
September 2, 2000
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis
G Martino, R Furlan, E Brambilla, et al.
Gene Therapy
|
June 13, 2001
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice
R Furlan, P L Poliani, P C Marconi, et al.
Magnetic Resonance Imaging
|
December 28, 1999
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents
J C Sipe, M Filippi, G Martino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 24, 1999
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study
R Furlan, M Filippi, A Bergami, et al.
Gene Therapy
|
August 18, 2001
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice
F Ruffini, R Furlan, P L Poliani, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Human Gene Therapy
|
December 16, 1998
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination
R Furlan, P L Poliani, F Galbiati, et al.
Gene Therapy
|
August 3, 2012
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia
C Maiorino, R Khorooshi, F Ruffini, et al.
Clinical Chemistry
|
March 3, 1999
TE671 cell-based ELISA for anti-acetylcholine receptor antibody determination in myasthenia gravis
D Franciotta, G Martino, E Brambilla, et al.
Journal of Clinical Pharmacology
|
April 29, 1998
Pharmacokinetics of isosorbide dinitrate in healthy volunteers after 24-hour intravenous infusion
A Bergami, R Bernasconi, S Caccia, et al.
Gene Therapy
|
August 25, 2006
HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice
R Furlan, A Bergami, E Brambilla, et al.
Journal of Neuroimmunology
|
September 2, 2000
Cytokines and immunity in multiple sclerosis: the dual signal hypothesis
G Martino, R Furlan, E Brambilla, et al.
Gene Therapy
|
June 13, 2001
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice
R Furlan, P L Poliani, P C Marconi, et al.
Magnetic Resonance Imaging
|
December 28, 1999
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents
J C Sipe, M Filippi, G Martino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 24, 1999
Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study
R Furlan, M Filippi, A Bergami, et al.
Gene Therapy
|
August 18, 2001
Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice
F Ruffini, R Furlan, P L Poliani, et al.
Page
of 3